Search Results - Kumar Kandadi Muralidharan

  • Showing 1 - 3 results of 3
Refine Results
  1. 1
    Cover Image

    Phase II Dose Selection for Alpha Synuclein-Targeting Antibody Cinpanemab (BIIB054) Based on Target Protein Binding Levels in the Brain by Mita Kuchimanchi, Michael Monine, Kumar Kandadi Muralidharan, Caroline Woodward, Natalia Penner

    Published 2020
    Connect to this object online.
    Book

    Save to List
    Saved in:
  2. 2
    Cover Image

    Population pharmacokinetics and standard uptake value ratio of aducanumab, an amyloid plaque-removing agent, in patients with Alzheimer's disease by Kumar Kandadi Muralidharan, Xiao Tong, Kenneth G. Kowalski, Raj Rajagovindan, Lin Lin, Samantha Budd Haberlain, Ivan Nestorov

    Published 2022
    Connect to this object online.
    Book

    Save to List
    Saved in:
  3. 3
    Cover Image

    Quantitative systems pharmacology model for Alzheimer's disease to predict the effect of aducanumab on brain amyloid by Lin Lin, Fei Hua, Cristian Salinas, Carissa Young, Thierry Bussiere, Joshua F. Apgar, John M. Burke, Kumar Kandadi Muralidharan, Rajasimhan Rajagovindan, Ivan Nestorov

    Published 2022
    Connect to this object online.
    Book

    Save to List
    Saved in:

Search Tools: